The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review.
about
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicityTime course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyA systematic review of the association between fatigue and genetic polymorphisms.Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial.Review: the use of proteomics as a research methodology for studying cancer-related fatigue: a review.Fatigue in immune thrombocytopenia.Peripheral cytokines as a chemical mediator for postconcussion like sickness behaviour in trauma and perioperative patients: literature review.Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care.Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgeryCytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.Cancer-Related Fatigue, Version 2.2015.Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancerCytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS.Fatigue-based subgroups of breast cancer survivors with insomnia.Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine.Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.Patient-reported outcomes and survivorship in radiation oncology: overcoming the consReciprocal regulation of the neural and innate immune systems.Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatmentDevelopment of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).Neurobiological studies of fatigue.Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancerInflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study.I'm so tired: biological and genetic mechanisms of cancer-related fatiguePhysical activity type and intensity among rural breast cancer survivors: patterns and associations with fatigue and depressive symptoms.Development of a mouse model for assessing fatigue during chemotherapy.Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivorsTemporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchRole of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome.Low heart rate variability and cancer-related fatigue in breast cancer survivors.Cancer-related and treatment-related fatigue.Exercise and Cancer-related Fatigue.Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression.
P2860
Q26744675-5D154F9C-EDF7-479E-9CD9-7C4BE69277C6Q26863511-8FA02A6F-71A7-4AC2-A192-6D257CBE2DB0Q30239004-28293544-CD7C-4866-818A-6FF55949609CQ30354107-6A209D19-C958-4A4E-A533-F975BDBCD642Q30385237-D41CC583-6C4A-473C-BA8C-82DEC03C00AEQ33421555-CF255E9C-CABB-4851-9CCE-04CD0EBFD238Q33607485-FD89492F-2A37-454F-BC41-9A02740E1941Q33643052-179BAA48-7B65-496D-9D3E-F776F3377B82Q33666335-BB187D0C-7A41-4CD6-BFF7-627806F6B085Q33727960-21CAC926-E9E2-4478-888E-11AE5DFB91FCQ33813575-C3063BF8-3D93-49B6-86E2-A718D8A2B6AEQ33839314-38E5AB13-6048-40AD-8594-935EA81446A5Q33839327-A94BF22D-64C1-4C36-A8E5-FD3F72CF0022Q33878583-87D764CF-0589-4A14-B49A-6D4F8AD59244Q33910359-CBD81CE1-E50B-4C04-B1C5-D5782BA2ED03Q33916716-A9A7B31C-625B-4847-8F40-8C21D61A85EAQ33943246-57A0D65A-03F7-467C-BB33-BA571AD98A29Q33965263-33C69B3C-CBE0-4F4D-BD88-2BE1EEC06DEDQ34036124-90E76DE2-77CA-407B-AEC3-8FAF86915544Q34049743-33BAA618-C11B-49A8-8AE3-0A2E89BF5D15Q34124311-A5E27E90-1E58-4EF4-9014-8B62B1893BC3Q34206115-7F2540B7-3BE5-49C2-BBFA-2BA8D4FCF4E0Q34264688-7889B0CB-C44C-41F8-822C-A2BB6B3E05F4Q34273348-FC6FA51B-8BD1-4162-A793-2649E34393C3Q34290841-BA83D7B6-666F-494F-A299-76311FF28B4DQ34307724-2590B9F4-4C51-44D4-B4DE-850AB21EFFA2Q34317938-DE314626-0F2B-471B-8E80-052C53689E48Q34543971-DDC62CC0-A17C-4BC5-800D-FE5AD3F714A3Q34586601-2AB7911F-B38B-4569-AD52-1E598732A895Q34819916-04DCC84C-4E70-4053-8399-379799A7062AQ34878309-10CE0D8A-C62F-4F6D-BF52-9167F33EECBDQ34961213-3FBE4E19-42DA-420D-9CC1-6653EDA375E5Q35036908-89CDE194-5B51-41B7-B0C3-06E5ED002CC7Q35067446-20BA1BF8-D630-4CCF-A4D2-19E8FF63740EQ35120883-0D3252E5-1601-45B6-836C-A2D71D888B00Q35124414-90FDA51D-F3E8-48DD-ACA2-74F50A7B3553Q35130621-2E4296C3-9F0E-43FE-95E4-8BBC2FE836B3Q35164501-A9B835B6-B7C3-45AB-ACF9-39D517D6A899Q35165946-5F63E9B5-043D-4478-B8AF-517543EF3462Q35264807-6E0F39E0-8838-4A9E-9B48-CBC8EF5D99DA
P2860
The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The association between fatigu ...... tients: a quantitative review.
@ast
The association between fatigu ...... tients: a quantitative review.
@en
type
label
The association between fatigu ...... tients: a quantitative review.
@ast
The association between fatigu ...... tients: a quantitative review.
@en
prefLabel
The association between fatigu ...... tients: a quantitative review.
@ast
The association between fatigu ...... tients: a quantitative review.
@en
P2093
P1476
The association between fatigu ...... tients: a quantitative review.
@en
P2093
Christian Schubert
Joel E Dimsdale
Loki Natarajan
Paul J Mills
P304
P356
10.1016/J.BBI.2006.11.004
P577
2006-12-18T00:00:00Z